A detailed history of Adams Diversified Equity Fund, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Adams Diversified Equity Fund, Inc. holds 222,200 shares of ABBV stock, worth $43 Million. This represents 1.31% of its overall portfolio holdings.

Number of Shares
222,200
Previous 180,000 23.44%
Holding current value
$43 Million
Previous $32.8 Million 16.27%
% of portfolio
1.31%
Previous 1.18%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024

BUY
$154.79 - $180.76 $6.53 Million - $7.63 Million
42,200 Added 23.44%
222,200 $38.1 Million
Q1 2024

Apr 24, 2024

BUY
$159.82 - $182.1 $28.8 Million - $32.8 Million
180,000 New
180,000 $32.8 Million
Q1 2023

Apr 26, 2023

BUY
$144.61 - $166.54 $7.3 Million - $8.41 Million
50,476 Added 39.04%
179,776 $28.7 Million
Q4 2022

Feb 03, 2023

BUY
$138.31 - $165.87 $6.29 Million - $7.55 Million
45,500 Added 54.3%
129,300 $20.9 Million
Q3 2022

Oct 26, 2022

SELL
$134.21 - $153.93 $4.56 Million - $5.23 Million
-34,000 Reduced 28.86%
83,800 $11.2 Million
Q2 2022

Jul 27, 2022

SELL
$137.62 - $174.96 $13.6 Million - $17.3 Million
-98,800 Reduced 45.61%
117,800 $18 Million
Q1 2022

Apr 27, 2022

SELL
$131.98 - $163.75 $13.5 Million - $16.8 Million
-102,600 Reduced 32.14%
216,600 $35.1 Million
Q4 2021

Feb 11, 2022

BUY
$107.43 - $135.93 $11.9 Million - $15.1 Million
111,200 Added 53.46%
319,200 $43.2 Million
Q3 2021

Oct 27, 2021

SELL
$106.4 - $120.78 $12.2 Million - $13.8 Million
-114,200 Reduced 35.44%
208,000 $22.4 Million
Q2 2021

Jul 23, 2021

BUY
$105.21 - $117.21 $8.55 Million - $9.53 Million
81,300 Added 33.75%
322,200 $36.3 Million
Q4 2020

Feb 12, 2021

SELL
$80.49 - $108.67 $3.24 Million - $4.37 Million
-40,200 Reduced 14.3%
240,900 $25.8 Million
Q3 2020

Oct 20, 2020

BUY
$85.91 - $100.83 $5.64 Million - $6.61 Million
65,600 Added 30.44%
281,100 $24.6 Million
Q2 2020

Jul 23, 2020

SELL
$73.37 - $98.18 $7.87 Million - $10.5 Million
-107,200 Reduced 33.22%
215,500 $21.2 Million
Q4 2019

Jan 31, 2020

BUY
$72.13 - $90.25 $23.3 Million - $29.1 Million
322,700 New
322,700 $28.6 Million
Q3 2018

Oct 29, 2018

SELL
$88.91 - $98.84 $23.6 Million - $26.3 Million
-265,700 Closed
0 $0
Q1 2018

Apr 27, 2018

SELL
$92.01 - $123.21 $5.29 Million - $7.08 Million
-57,500 Reduced 17.79%
265,700 $25.1 Million
Q4 2017

Feb 13, 2018

SELL
$89.56 - $98.21 $5.09 Million - $5.58 Million
-56,800 Reduced 14.95%
323,200 $31.3 Million
Q3 2017

Oct 30, 2017

BUY
$69.85 - $89.22 $26.5 Million - $33.9 Million
380,000
380,000 $33.8 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $342B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Adams Diversified Equity Fund, Inc. Portfolio

Follow Adams Diversified Equity Fund, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adams Diversified Equity Fund, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Adams Diversified Equity Fund, Inc. with notifications on news.